Results vary based on skin quality, fat distribution, and chosen technique, but most patients report high satisfaction when realistic expectations are established during consultation
Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
But real, lasting change depends on addressing harmful behaviour over weeks and months not just silencing the cravings temporarily
In some embodiments the indication is (ii)
Source: JAAD Case Reports